Drug intelligence / Profile preview

l-arginine + proanthocyanidine + l-glutathione

Development stage
Unknown
Lead developer
Novogen Captab
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

L-arginine + proanthocyanidine + L-glutathione is a combination nutritional supplement developed and marketed by Novogen Captab. The formulation combines three active ingredients to support vascular health and improve blood circulation. **L-arginine** is an amino acid that serves as a precursor for nitric oxide synthesis, acting as a vasodilator to relax and expand blood vessels. **Proanthocyanidine**, typically extracted from grape seeds, is a polyphenolic antioxidant that reduces oxidative stress and inflammation within the vasculature. **L-glutathione** is a tripeptide antioxidant that helps protect nitric oxide from oxidative degradation, thereby enhancing its bioavailability and functional effect. This combination is primarily indicated for conditions associated with vascular dysfunction, including pre-eclampsia, intrauterine growth restriction (IUGR), hypertension, diabetes-related vascular complications, and erectile dysfunction. It is approved for use as a dietary supplement in India.

Other names
L-Arginine, Proanthocyanidine, L-Glutathione
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on l-arginine + proanthocyanidine + l-glutathione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on l-arginine + proanthocyanidine + l-glutathione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call